Premium
Immediate hyperbaric oxygen after tooth extraction ameliorates bisphosphonate‐related osteonecrotic lesion in rats
Author(s) -
Liu SaoShen,
Lin TzuYi,
Fu Earl,
Hsia YiJan,
Chiu HsienChung,
Tu HsiaoPei,
Chiang ChengYang
Publication year - 2019
Publication title -
journal of periodontology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.036
H-Index - 156
eISSN - 1943-3670
pISSN - 0022-3492
DOI - 10.1002/jper.18-0761
Subject(s) - medicine , molar , hyperbaric oxygen , lesion , osteonecrosis of the jaw , zoledronic acid , bisphosphonate , histology , dexamethasone , dentistry , anesthesia , surgery , osteoporosis
Background This study aims to assess whether hyperbaric oxygen (HBO) applied immediately after tooth extraction could ameliorate medication‐related osteonecrosis of the jaw in rats. Methods To evaluate whether osteonecrosis could be successfully induced, healing of extraction maxillary molars was examined in 40 female Sprague Dawley rats received zoledronic acid (7.5 µg/kg) plus dexamethasone (1 mg/kg). Rats were divided into four groups, receiving zero, two, four, or seven injection(s) for 7 days, respectively. Effect of HBO, pressurized to 2.5 atmospheres absolute (ATA) at rate of 0.15 ATA/min with 100% oxygen for 90 minutes, applied immediately after tooth extraction, on the development of osteonecrosis was evaluated. Lesions among groups were compared by size of ulceration, exact area (mm 2 ) or relative area (%), and by histology. Results Unhealed ridge was observed in all nine rats in four and seven injection groups, but none of 10 rats in the control (non‐injection) group. Immediate HBO significantly reduced the lesions in rats that received four injections, regardless of the distribution and the total/relative areas of lesions ( P <0.01). Histological findings showed the lesions were uncovered epithelium and severe tissue inflammation. Conclusion This is the first in vivo study demonstrating the HBO applied immediately after tooth extraction effectively decreases the development of medication‐related osteonecrosis.